SEROPHENE (clomiphene citrate) by Rubicon Biotechnology is clinical pharmacology action clomiphene citrate is a drug of considerable pharmacologic potency. First approved in 1982.
Drug data last refreshed 3h ago · AI intelligence enriched 2w ago
Serophene (clomiphene citrate) is an oral selective estrogen receptor modulator that induces ovulation in anovulatory women by competitively binding estrogen receptors in the hypothalamus and pituitary, triggering a cascade of gonadotropin release and follicular development. It is a first-line fertility treatment for women with ovulatory dysfunction desiring pregnancy. The drug works through mixed estrogenic and antiestrogenic properties that culminate in a preovulatory gonadotropin surge and follicular rupture.
With lifecycle status approaching loss of exclusivity and moderate competitive pressure (30%), brand team focus is shifting toward generic transition planning and retained market share in specialty fertility settings.
CLINICAL PHARMACOLOGY Action Clomiphene citrate is a drug of considerable pharmacologic potency. With careful selection and proper management of the patient, clomiphene citrate has been demonstrated to be a useful therapy for the anovulatory patient desiring pregnancy. Clomiphene citrate is capable…
Worked on SEROPHENE at Rubicon Biotechnology? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Myo-inositol Versus Clomiphene Citrate in PCOS
Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women
Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome
Clomiphene Citrate (CC) Co-treatment With HP Urinary FSH vs HP Urinary FSH in CC-resistant PCOS
Working on Serophene during its LOE approach phase presents a challenging career opportunity requiring crisis management and transition planning skills rather than growth-oriented strategy. Professionals on this team develop expertise in generic defense, market segmentation, and lifecycle management—valuable competencies for portfolio roles overseeing other products approaching exclusivity loss.